Role of Next Generation Sequencing (NGS) in Hematological Disorders
Sequencing techniques are at the forefront of medical diagnostics in the current era of personalized medicine and targeted therapy. These techniques can identify the exact genetic change at the nucleotide level which aids in delineating the molecular pathogenesis and may also help in development of tailored therapy. Different sequencing approaches can be used for either the discovery of new genetic aberrations or checking the known genetic change for diagnostic purposes, depending on the requirement. Next generation sequencing (NGS) refers to the post-Sanger technologies, i.e., sequencing technologies developed after Sanger sequencing. So, NGS includes a group of technologies having the capacity to sequence large segments of genome or entire genome in high-throughput experiments to detect genetic aberrations in a much faster and reliable way . The current high-throughput NGS techniques, which are also being made available at affordable costs, are gradually replacing the conventional or first generation sequencing techniques in the clinical settings. In this chapter, the basic workflow of next generation sequencing (NGS) and its application in hematological disorders has been briefly discussed.
KeywordsNext generation sequencing NGS in hematology Applications of NGS NGS workflow
- 12.Arber DA, Orazi A, Hasserjian RP, Brunning RD, Le Beau MM, Porwit A, et al. Introduction and overview of the classification of myeloid neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC; 2017. p. 16–27.Google Scholar
- 24.Carlberg K, Bose N, Deng J, Lal A, Erlich H, Calloway C. Towards the development of a noninvasive prenatal test for beta-thalassemia: utilization of probe capture enrichment and next generation sequencing. Blood. 2016;128(22):3622.Google Scholar
- 28.Agarwal AM, Reading NS, Frizzell K, Shen W, Sorrells S, Salama ME, et al. Using a next generation sequencing panel to discover the obscure causes of hereditary hemolytic anemias. Blood. 2016;128(22):2433.Google Scholar
- 29.Russo RAI, Manna F, Gambale A, Pignataro P, De Rosa G, Iolascon A. RedPlex: a targeted next generation sequencing-based diagnosis for patients with hereditary hemolytic anemias. Haematologica. 2016;101(s1):1.Google Scholar
- 32.Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):249–55.CrossRefGoogle Scholar